The Right Price: A Wealth of Knowledge!
Why is The Right Price by Peter Neumann, Dan Ollendorf and colleagues the book of the year?
Amongst the plethora of -often very good- contributions to health economics and more specifically to cost-effectiveness of choices, analyses as well as perspectives from internationally recognised experts at Tufts such as Dr Peter Neumann or Dr Dan Ollendorf add consistent value to the field: they enlighten, bring unparalleled value and challenge assumptions.
In sum, they make for excellent research and offer a wealth of knowledge to the health economics and the broader health system ecosystem. Their new book is the acclaimed "The Right Price" published by Oxford University Press (click here to order it) is now an Amazon bestseller: check it out.....and make sure you order it!
In the third act of his play Lady Wintermere's Fan, Oscar Wilde wrote this well-known aphorism: "a cynic is a man who knows the price of everything and the value of nothing".
Well, in The Right Price it seems the team of writers achieved much more, proving knowledgeable in the pricing policies and practices but underlining the importance of value-based factors and choices across drug policies.
At a time where the importance of patient-centred care health systems is paramount and where social participation as well as social value of policies cannot be over-emphasised, this is the book every health professional needs to understand what can go wrong in pharmaceutical markets, as well as how to rebase pharmaceutical market values. As explained by their publishers:
The Right Price sheds light on the controversial topic of drug pricing by providing an accessible guide to pharmaceutical markets and analytic techniques used to measure the value of drug therapies. It illustrates the need for value-based pricing through real-life stories of patients and their experiences with the drug industry and explains why simple solutions like price controls and the importation of cheaper drugs from other countries are problematic.
As expected, this book is incredibly meaningful, thought-provoking and a game changer: public and private sector interactions, drug pricing and market practices: this is sharp, clear and will resonate for years.